HEALTH AND MEDICINE COUNSEL

Lobbying for ALPHA-1 FOUNDATION · Committed to finding a cure and improving lives with Alpha-1 Antitrypsin Deficiency.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Florida · $10,000.00 income · posted Jul 17, 2026

Lobbying activity 2

Budget/Appropriations

Funding NIH, CDC, HRSA, CMS, FDA

Health Issues

John Walsh Alpha-1 Home Infusion Act, SOAR Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.